Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.04.15.648967

Brain-derived exosome biomarkers of neuroinflammation and neuronal functional iron deficiency in newborns of overweight-obese mothers

Abstract

BackgroundNon-infectious neuroinflammation (NINI) in early life and neonatal neural iron deficiency (nID) have been proposed to contribute to neurodevelopmental dysfunction and disorders, including autism, through toxic effects on neural cells and impaired molecular signaling. Early detection of NINI and nID may enable interventions to restore neurodevelopmental homeostasis and reduce long-term impact. However, such diagnoses are impossible due to ethical reason to access to the central nervous system (e.g., lumbar puncture) when there is no suspicion of brain infection (e.g., meningitis). MethodsWe refined a methodology to isolate and quantify inflammatory and iron-regulatory proteins in high-quality brain-derived extracellular vesicles (BDEVs) from human umbilical cord blood. A preclinical model was used to validate that BDEV contents reflect the brain microenvironment. We then applied this approach to evaluate biomarkers of NINI and nID in BDEVs isolated from cord plasma of newborns of mothers with obesity, a non-infectious pro-inflammatory gestational condition and a risk factor for nID. FindingsPlasma BDEV analytes correlated more strongly with brain analytes and showed stronger associations among functionally related molecules compared with whole plasma analytes. Maternal obesity induced an anti-inflammatory response in the brain compartment, a pro-inflammatory response in the periphery, and functional nID. InterpretationBDEVs may provide a more sensitive representation of the brain microenvironment than blood-based measures (e.g., plasma), enabling non-invasive, early detection of infants with NINI and neonatal nID. FundingSupported by NIH, the Masonic Institute for Developing Brain, Hennepin Healthcare Research Institute, UnityPoint Health Meriter Foundation, and American Academy of Pediatrics Resident Research Grant. Research in ContextO_ST_ABSEvidence before this studyC_ST_ABSPrevious studies hypothesized that gestational inflammatory environments (e.g., maternal obesity) increase risk of neonatal neural iron deficiency (nID), neuroinflammation, and neurodevelopmental disorders. However, assessing non-infectious neuroinflammation (NINI) in infants from these high-risk groups is not feasible or clinically justifiable using invasive methods (e.g., cerebrospinal fluid collection), and analytes from whole blood or plasma may not accurately reflect brain physiological status. Added value of this studyWe refined a protocol to isolate brain-derived extracellular vesicles (BDEVs) from a small amount of plasma sample (100 {micro}L) and characterized their contents to approximate brain physiology. We demonstrated that BDEVs more accurately reflect brain status compared with whole plasma. In newborns of mothers with obesity during pregnancy, we found evidence of a low-grade peripheral inflammation accompanied by a protective anti-inflammatory response in the brain. Maternal obesity was also found to induce neonatal nID. Implications of all the available evidenceBDEVs can serve as an accurate, non-invasive tool to assess brain condition. In clinical settings, this approach may be used for early diagnosis, monitoring disease progression, and evaluating treatment effects. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=139 SRC="FIGDIR/small/648967v2_ufig1.gif" ALT="Figure 1"> View larger version (52K): org.highwire.dtl.DTLVardef@108caa9org.highwire.dtl.DTLVardef@311ecdorg.highwire.dtl.DTLVardef@dd4086org.highwire.dtl.DTLVardef@1b747ea_HPS_FORMAT_FIGEXP M_FIG C_FIG

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tran, P. V., Harris, A. C., Maxim, Z. L., Munirathinam, M., Muelken, P., Javadova, N., Kruttiventi, S., Kling, P. J., Baack, M. L., Georgieff, M. K.. 2025-04-20. Brain-derived exosome biomarkers of neuroinflammation and neuronal functional iron deficiency in newborns of overweight-obese mothers. https://doi.org/10.1101/2025.04.15.648967

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗